Attaphol Pawarode
Overview
Explore the profile of Attaphol Pawarode including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Georges G, Khanna D, Wener M, Mei M, Mayes M, Simms R, et al.
Arthritis Rheumatol
. 2024 Dec;
PMID: 39624016
Objective: Two randomized trials for patients with diffuse systemic sclerosis (SSc) demonstrated an overall survival (OS) and event-free survival (EFS) advantage of autologous hematopoietic stem cell transplantation (AHSCT) using CD34+...
2.
Mercadal S, Ahn K, Allbee-Johnson M, Ganguly S, Ramakrishnan Geethakumari P, Hong S, et al.
Haematologica
. 2024 Sep;
110(1):218-221.
PMID: 39234871
No abstract available.
3.
Frame D, Geer M, Kasha S, Markstrom D, Scappaticci G, Feeney T, et al.
Front Immunol
. 2024 Jul;
15:1403145.
PMID: 38947326
Introduction: Lymphodepleting chemotherapy (LDC) is critical to CAR T-cell expansion and efficacy. Despite this, there is not a consensus in the literature regarding the optimal LDC regimen, including dose and...
4.
Jain T, Estrada-Merly N, Salas M, Kim S, DeVos J, Chen M, et al.
Blood Adv
. 2024 Jun;
8(16):4281-4293.
PMID: 38916866
We evaluate the impact of donor types on outcomes of hematopoietic cell transplantation (HCT) in myelofibrosis, using the Center for International Blood and Marrow Transplant Research registry data for HCTs...
5.
Etra A, Jurdi N, Katsivelos N, Kwon D, Gergoudis S, Morales G, et al.
Blood Adv
. 2024 Apr;
8(12):3284-3292.
PMID: 38640195
Graft-versus-host disease (GVHD) is a major cause of nonrelapse mortality (NRM) after allogeneic hematopoietic cell transplantation. Algorithms containing either the gastrointestinal (GI) GVHD biomarker amphiregulin (AREG) or a combination of...
6.
Vasbinder A, Hoeger C, Catalan T, Anderson E, Chu C, Kotzin M, et al.
JACC CardioOncol
. 2024 Jan;
5(6):821-832.
PMID: 38205002
Background: Hematopoietic stem cell transplantation (HSCT) is associated with various cardiovascular (CV) complications. Objectives: We sought to characterize the incidence and risk factors for short-term and long-term CV events in...
7.
Vasbinder A, Catalan T, Anderson E, Chu C, Kotzin M, Murphy D, et al.
J Am Heart Assoc
. 2023 Dec;
13(1):e033599.
PMID: 38158222
Background: Evidence guiding the pre-hematopoietic stem cell transplantation (HSCT) cardiovascular evaluation is limited. We sought to derive and validate a pre-HSCT score for the cardiovascular risk stratification of HSCT candidates....
8.
Riwes M, Golob J, Magenau J, Shan M, Dick G, Braun T, et al.
Nat Med
. 2023 Oct;
29(11):2805-2813.
PMID: 37857710
Evaluation of the impact of dietary intervention on gastrointestinal microbiota and metabolites after allogeneic hematopoietic stem cell transplantation (HCT) is lacking. We conducted a feasibility study as the first of...
9.
Magenau J, Jaglowski S, Uberti J, Farag S, Riwes M, Pawarode A, et al.
Blood
. 2023 Aug;
143(1):21-31.
PMID: 37647633
Patients who undergo human leukocyte antigen-matched unrelated donor (MUD) allogeneic hematopoietic stem cell transplantation (HSCT) with myeloablative conditioning for hematologic malignancies often develop acute graft-versus-host disease (GVHD) despite standard calcineurin...
10.
Tamari R, McLornan D, Ahn K, Estrada-Merly N, Hernandez-Boluda J, Giralt S, et al.
Blood Adv
. 2023 May;
7(15):3993-4002.
PMID: 37134306
To develop a prognostic model for patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) for myelofibrosis (MF), we examined the data of 623 patients undergoing allo-HCT between 2000 and 2016 in...